Precision Oncology
The latest news on biomarker-guided cancer care.
Reveal Genomics' HER2DX Assay De-Escalates Early Breast Cancer Treatment in Real-World Study
Premium
The observational study measured how physicians changed treatment plans after seeing HER2DX results and how patients did on the new plans.
Anixa Biosciences Nabs Option to Develop Cancer Vaccines With Verdi Solutions
If Anixa exercises its rights, Verdi and Anixa will collaborate on trials in the US, while Verdi will continue developing personalized vaccines in Europe.
Elevation Oncology Terminates CLDN18.2-Targeted ADC, Reduces Workforce
The company said initial efficacy results from a Phase I trial did not provide a competitive benefit-risk profile in CLDN18.2-positive gastric and gastroesophageal cancer.
Everest Medicines Cleared by FDA to Study Cancer Vaccine in US Clinical Trials
The mRNA cancer vaccine, EVM14, induces an immune response to multiple tumor-associated antigens.
Angle Hoping to Continue Developing Parsortix HER2 CTC Assay With BlissBio, Eisai
Although Eisai decided not to option a HER2-targeted drug under a deal with BlissBio, Angle wants to keep working with the firms to advance its CTC technology.